Nataliya Agafonova Nataliya Agafonova, M.D., Chief Medical Officer, Longeveron Planned single, pivotal Phase 2/3 clinical trial, if positive, acceptable for...
XI’AN, China, March 20, 2025 (GLOBE NEWSWIRE) -- Bon Natural Life Limited (Nasdaq: BON) ("BON" or the "Company"), a leading...
$10 Million Acquisition Bolsters FITY's Leadership with Dr. Gennaro D'Urso as CEO and ChairmanMELBOURNE, Fla., March 20, 2025 (GLOBE NEWSWIRE)...
As Western North Carolina continues to rebuild after the hurricane's devastating impact, Aeroflow Health has provided aid to the WE...
WOODHAVEN, N.Y., March 20, 2025 (GLOBE NEWSWIRE) -- What if the key to better hydration and muscle recovery wasn’t in...
Former SVP and Franchise Head for US Oncology at Jazz Pharmaceuticals, with established track record for leading a portfolio of...
BPDCN is an aggressive hematologic malignancy with a historically poor prognosisVisualDx is a clinical decision support system used by more...
FREDERICK, Md., March 20, 2025 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global leader in disinfection...
Jiangxi, China, March 20, 2025 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (NASDAQ: UPC) (“Universe Pharmaceuticals” or the “Company”), a pharmaceutical...
NEW YORK, March 20, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical...
Continued progress with growing global patent portfolio to over 80 issued patents and 40 pending patent applications Proprietary sensing and...
JUPITER, Fla., March 20, 2025 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI),...
HORSHAM, Pa., March 20, 2025 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical...
Conference call will be held today, Thursday, March 20 at 9:00 am ETCARMEL, Ind., March 20, 2025 (GLOBE NEWSWIRE) --...
WILMINGTON, Del., March 20, 2025 (GLOBE NEWSWIRE) -- The U.S. Department of Agriculture has recently issued a Response to the...
BETHESDA, Md., March 20, 2025 (GLOBE NEWSWIRE) -- CorVista Health today announced the upcoming poster presentation of new data on...
Emergent BioSolutions will lead commercial launch efforts to increase access to intranasal naloxone and combat opioid overdose poisonings in CanadaLONDON...
Achieved Q4 2024 PEMGARDA™ (pemivibart) net product revenue of $13.8 million, representing 48% growth over Q3 2024 net product revenue...
The Data Safety Monitoring Board (DSMB) identified no safety concerns, and recommended continuation of BriaCell’s pivotal Phase 3 study of...
BOSTON, March 20, 2025 (GLOBE NEWSWIRE) -- Medera Inc. (“Medera”), a clinical-stage biopharmaceutical company focused on cardiovascular diseases with high...